Escitalopram for perimenopausal depression: An open-label pilot study

Journal of Women's Health

Volumn 15, Issue 7, 2006, Pages 857-861

  Freeman, Marlene P ^a   Hill, Rebecca ^a   Brumbach, Barbara H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; SEROTONIN UPTAKE INHIBITOR; CITALOPRAM;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HAMILTON SCALE; HORMONE SUBSTITUTION; HUMAN; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; VASOMOTOR REFLEX; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITALIZATION; MIDDLE AGED; TREATMENT OUTCOME; WOMEN'S HEALTH;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSION; FEMALE; HUMANS; MIDDLE AGED; PERIMENOPAUSE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 33847696631     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.857     Document Type: Article

References (22)

1. Weissman MM, Leaf PJ, Holzer CE, Myers JK, Tishler GL. The epidemiology of depression. An update of sex differences in rates. J Affective Disord 1984; 7:179.
2. Kessler RC. Epidemiology of women and depression. J Affective Disord 2003;74:5.
3. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: A justification for further study. Am J Psychiatry 1991;148:844.
4. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347.
5. World Health Organization. Research on the menopause in the 1990s: Report of a WHO scientific group. Geneva: WHO Technical Report Series 866, 1996.
6. Clinical challenges of perimenopause: Consensus opinion of the North American Menopause Society. Menopause 2000;7:5.
7. Rossouw JE, Anderson GL, Prentice RL, et al. for the Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321.
8. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 2004;291:47.
9. McIntyre RS, Konarski JZ, Grigoriadis S, et al. Hormone replacement therapy and antidepressant prescription patterns: A reciprocal relationship. Can Med Assoc J 2005;172:57.
10. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxi1) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17.
11. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23:337.
12. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578.
13. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 2000; 356:2059.
14. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 2003; 289:2827.
15. Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depress Anxiety 2005; 22:94.
16. Barton DL, Loprinzi CL, Novotny P, et al. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 2003;1:47.
17. Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL, Cohen LS. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry 2003;64:473.
18. Joffe H, Groninger H, Soares CN, Nonacs R, Cohen LS. An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J Womens Health Gend Based Med 2001;10:999.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
20. Stellato RK, Crawford SL, McKinlay SM, Longcope CL. Can follicle-stimulating hormone be used to define menopausal status? Endocr Pract 1998;4:137.
21. Blatt MH, Weisbader H, Kupperman HS. Vitamin E and climacteric syndrome. Arch Intern Med 1953;91:792.
22. Guy W. ECDEU assessment manual for psychopharmacology. DHEW publication No. (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976.